Aqueduct Critical Care is focused on the development and commercialization of disruptive technologies in the market for Cerebrospinal Fluid (CSF) drainage. Our technology innovation is intended to increase the ease of use and safety of managing patients with CSF drains.
Elevated intracranial pressure (ICP) can be a result of acute hydrocephalus or other acute conditions such as traumatic brain injury, tumors, and infections. Under these circumstances, neurosurgeons will often place an external CSF drain to prevent secondary brain injury or death. The current technology used involves a gravity controlled burette that is raised or lowered to adjust the Cerebrospinal Fluid (CSF) flow rate. The current systems must be maintained by the nursing staff and require continuous attention.
The Smart External Drain is designed to eliminate the need for constant manual measurements, adjustments and interventions. The product can enhance patient mobility allowing the patient undergoing tests and physical therapy to continue draining. The Smart External Drain may potentially improve patient safety providing patient specific settings for control and alarms for unwanted conditions.
In the future, the Aqueduct technology can also be applied to temporary CSF drainage from other body locations, such as a lumbar drain. For diagnosing normal pressure hydrocephalus (NPH), the external lumbar drain is considered by many experts as the best indicator for a positive outcome for treatment with an implantable shunt. As many as 10% of all patients identified as having dementia may have NPH and effecting up to 375,000 Americans.1,2 NPH diagnostic procedures are predicted to grow as the population ages and as NPH awareness among clinicians and consumers improves.
2 National Institute of Neurological Disorders and Stroke, NIH Publ. #13-385